Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home Companiesbiote Corp

biote Corp

Healthcare Medical Care Facilities
PortfolioPortfolio WatchlistWatchlist
Company price
1.06 USD 0.02 ( 1.92%)
Last update at 2026-11-06T21:00:00Z
VOLUME
53368
Market Cap
82.73M
P/E
3.04

Momentum Score

…

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1.02
Low
1.09
High
52 Week Price Range
1.27
Low
4.75
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Biote Corp operates a network of clinics and telehealth services delivering hormone optimization, diagnostics, and related practitioner training and products for adult men and women. Long-term growth could be supported by aging demographics, rising demand for personalized hormone therapy, and expansion of clinic and virtual-care footprints with recurring treatment revenue. Investors may find the company attractive for its niche in consumer-facing endocrine care that appears positioned to scale through additional locations and digital channels.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
1.04
Dividend Yield
-
Revenue TTM
192.22M
Revenue Per Share
6.14
Gross Profit TTM
137.36M
Debt / Equity
-1.88
ROE
-
Net Debt
85.80M
ROCE
56.77%
Diluted EPS TTM
0.73

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 37.58M 1.02M -0.12M 1.71M 32.91M
Minority interest -4.55M 3.11M -0.72M -2.29M -
Net income 27.05M 3.16M 3.32M 1.32M 32.62M
Selling general administrative 101.81M 107.45M 93.42M 165.50M 49.05M
Selling and marketing expenses - - - 4.63M 4.91M
Gross profit 137.36M 139.06M 127.48M 110.38M 90.58M
Reconciled depreciation 3.67M 3.57M 2.04M 2.20M 1.40M
Ebit 35.55M 12.02M 38.74M -60.72M 34.56M
Ebitda 39.22M 15.59M 39.54M -57.45M 34.58M
Depreciation and amortization 3.67M 3.57M 0.79M 3.27M 0.02M
Operating income 35.55M 31.61M 28.66M -60.72M 34.56M
Other operating expenses 156.67M 165.58M 156.70M 225.68M 104.83M
Interest expense 10.96M 11.00M 6.36M 5.09M 1.67M
Tax provision 5.99M 0.97M 5.86M 0.39M 0.29M
Net interest income -10.96M -11.00M -7.43M -5.09M -1.67M
Income tax expense 5.99M 0.97M 2.68M 0.39M 0.29M
Total revenue 192.22M 197.19M 185.36M 164.96M 139.40M
Total operating expenses 101.81M 107.45M 98.83M 171.10M 56.02M
Cost of revenue 54.86M 58.13M 57.88M 54.58M 48.82M
Total other income expense net 2.03M -30.59M -28.78M 62.43M -1.66M
Net income from continuing ops 31.60M 0.05M -2.07M 1.32M 32.62M
Net income applicable to common shares - - - - 32.62M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 107.61M 122.37M 155.29M 111.64M 54.33M
Intangible assets 4.27M 9.38M 4.97M 5.07M 4.55M
Other current assets 4.62M 6.24M 4.22M 3.82M 3.94M
Total liab 158.01M 224.57M 191.84M 169.92M 50.20M
Total stockholder equity -58.54M -105.93M -29.40M -44.46M 4.12M
Other current liab 28.31M 35.97M 8.50M 6.27M 6.01M
Common stock 0.00M 0.00M 0.01M 0.01M 317.50M
Capital stock 0.00M 0.00M 0.01M 0.01M 0.00M
Retained earnings -49.55M -100.30M -29.39M -44.46M 4.17M
Other liab - - - 37.14M 0.80M
Good will 5.83M 5.83M - - -
Other assets - - 0.00M - -
Cash 24.12M 39.34M 89.00M 79.23M 26.77M
Total current liabilities 44.99M 51.51M 22.21M 18.77M 17.31M
Current deferred revenue 3.02M 2.96M 3.00M 1.97M 1.71M
Net debt 85.80M 71.52M 25.87M 41.20M 10.57M
Short term debt 6.84M 6.77M 6.56M 6.42M 5.25M
Short long term debt 6.25M 6.25M 6.25M 6.25M 5.00M
Short long term debt total 109.92M 110.86M 114.87M 120.43M 37.34M
Other stockholder equity -8.96M -5.60M - -13.81M -317.50M
Property plant equipment - - - 3.56M 2.69M
Total current assets 54.67M 68.13M 122.34M 101.18M 47.09M
Net tangible assets - - - -49.53M -0.43M
Net receivables 6.87M 7.70M 8.17M 6.95M 5.23M
Long term debt 100.78M 101.20M 106.63M 112.09M 31.96M
Inventory 19.06M 14.85M 20.95M 11.18M 9.62M
Accounts payable 6.83M 5.81M 4.16M 4.11M 4.35M
Accumulated other comprehensive income -0.03M -0.04M -0.01M -0.01M -0.04M
Non currrent assets other 4.60M 0.07M 4.97M 5.07M -317.58M
Non current assets total 52.94M 54.24M 32.95M 10.47M 7.25M
Capital lease obligations 2.89M 3.41M 1.99M 2.09M 0.38M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -18.80M -22.02M -1.84M -3.81M
Change to liabilities - - - 0.38M 1.23M
Total cashflows from investing activities -6.86M -18.80M -2.71M - -3.81M
Net borrowings -1.25M -6.25M -6.25M 84.38M -5.00M
Total cash from financing activities -43.55M -76.08M -14.38M 63.46M -20.34M
Change to operating activities - - - - 3.82M
Net income 27.05M 0.05M 3.32M 1.32M 32.62M
Change in cash -15.22M -49.66M 9.77M 52.47M 9.56M
Begin period cash flow 39.34M 89.00M 79.23M 26.77M 17.21M
End period cash flow 24.12M 39.34M 89.00M 79.23M 26.77M
Total cash from operating activities 35.19M 45.24M 26.88M -9.16M 33.72M
Issuance of capital stock 0.14M 0.28M 0.29M 0.44M -
Depreciation 3.67M 3.57M 2.99M 2.20M 1.40M
Other cashflows from investing activities -1.85M -0.53M -2.35M - -
Dividends paid 1.73M 4.74M 8.69M 12.89M 11.40M
Change to inventory -6.24M 3.71M -6.10M -1.71M -5.76M
Change to account receivables -0.96M -2.27M -0.51M -1.56M -0.75M
Sale purchase of stock -3.37M -5.60M 14.52M -0.42M -
Other cashflows from financing activities -37.58M -59.77M 0.42M 116.95M -3.94M
Change to netincome - - - 24.84M 0.94M
Capital expenditures 5.01M 6.43M 2.71M 1.84M 3.81M
Change in working capital -8.25M 9.93M -8.93M -35.81M -1.46M
Stock based compensation 8.92M 8.73M 9.06M 82.18M -
Other non cash items -0.17M 25.85M 19.72M -58.30M 1.16M
Free cash flow 30.18M 38.81M 24.17M -10.99M 29.91M

Peer Comparison*

Sector: Healthcare Industry: Medical Care Facilities

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
BTMD
biote Corp		 0.02
1.92%		 1.06 3.04 4.69 0.43 2.96 0.82 3.02
HCA
HCA Healthcare, Inc.		 -12.49
2.46%		 494.99 14.27 13.46 1.21 291.34 1.83 8.99
THC
Tenet Healthcare Corporation		 -3.13
1.09%		 283.33 10.08 12.66 0.96 4.57 1.43 5.80
FSNUY
Fresenius SE & Co KGaA ADR		 0.06
0.42%		 14.62 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc		 -
-%		 5.28 62.50 35.97 0.30 2.32 0.16 3.90

Profile*

biote Corp

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.

1875 W. Walnut Hill Ln #100, Irving, TX, United States, 75038

844 604 1246

https://www.biote.com

223

Name Title Year Born
Mr. Marc D. Beer Exec. Chairman 1965
Ms. Teresa S. Weber CEO & Director 1953
Mr. Cary M. Paulette Chief Revenue Officer 1962
Mr. Samar Kamdar Chief Financial Officer 1979
Mr. Joe Butler Chief Information Officer 1962
Ms. Mary Elizabeth Conlon VP of Bus. Devel. & Gen. Counsel 1980
Mr. Richard Kevin Key Chief Digital Officer & Head of Marketing 1970
Ms. Jennifer Schimmel Director of HR & Talent 1973
Mr. Jade Beutler Head of Nutraceuticals 1963
Dr. Ross W. McQuivey M.D. Chief Medical Officer & Member of Medical Advisory Board 1972

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…